Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
T-C Teh, N-Y Nguyen, DM Moujalled, D Segal, G Pomilio, S Rijal, A Jabbour, K Cummins, K Lackovic, P Blombery, E Thompson, PG Ekert, G Lessene, SP Glaser, DCS Huang, AW Roberts, MA Guthridge, AH Wei
Leukemia | NATURE PUBLISHING GROUP | Published : 2018
Awarded by National Health and Medical Research Council
We thank Leukemia Foundation, Victorian Cancer Agency, Arrow Bone Marrow Transplant Foundation, Leukemia Lymphoma Society, Australian Cancer Research Foundation, Victorian State Government Operational Infrastructure Support (OIS) and the National Health and Medical Research Council (fellowships and grants including an Independent Infrastructure Support Scheme grant 9000220); we also thank Abbvie for providing venetoclax and A-1155463.